Luzindole
Alternative Names: N 0774Latest Information Update: 22 May 1997
At a glance
- Originator Whitby Pharmaceuticals
- Class Antidepressants; Small molecules; Tryptamines
- Mechanism of Action Melatonin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mood disorders
Most Recent Events
- 22 May 1997 Discontinued-Phase-Unspecified for Affective disorders in USA (Unknown route)
- 03 Jan 1997 No-Development-Reported for Affective disorders in USA (Unknown route)